Marzo, Lovely .
HRN: 10-69-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2022
CEFTRIAXONE 1G (VIAL)
10/04/2022
10/11/2022
IV
950mg
Q12h
Peritonitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes